Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Highwoods Properties
HIW
$3.73B
| $12.8M | 0.02% |
253,200
+22,800
| +10% | +$1.16M |
|
1102
Benchmark Electronics
BHE
$2.86B
| $12.8M | 0.02% |
397,150
+82,900
| +26% | +$2.67M |
|
1103
Affiliated Managers Group
AMG
$9.61B
| $12.8M | 0.02% |
+76,969
| New | +$12.3M |
|
1104
KRONOS Worldwide
KRO
$705M
| $12.7M | 0.02% |
699,300
+61,400
| +10% | +$1.09M |
|
|
FONR
1105
DELISTED
Fonar
FONR
| $12.7M | 0.02% |
457,223
-19,493
| -4% | -$447K |
|
|
EXPR
1106
DELISTED
Express, Inc.
EXPR
| $12.7M | 0.02% |
93,965
+77,710
| +478% | +$12.1M |
|
1107
Helen of Troy
HELE
$658M
| $12.7M | 0.02% |
134,786
+53,376
| +66% | +$4.97M |
|
|
EARN
1108
Ellington Residential Mortgage REIT
EARN
$165M
| $12.7M | 0.02% |
864,302
+212,702
| +33% | +$3.16M |
|
|
FFKT
1109
DELISTED
Farmers Capital Bank Corp
FFKT
| $12.7M | 0.02% |
328,300
-6,100
| -2% | -$242K |
|
|
VISN
1110
Vistance Networks Inc
VISN
$2.67B
| $12.6M | 0.02% |
332,400
+212,400
| +177% | +$8.2M |
|
|
GOV
1111
DELISTED
Government Properties Income Trust
GOV
| $12.6M | 0.02% |
689,500
-295,000
| -30% | -$6.42M |
|
1112
Travelers Companies
TRV
$81.4B
| $12.6M | 0.02% |
99,700
-31,172
| -24% | -$3.84M |
|
1113
Interparfums
IPAR
$3.99B
| $12.6M | 0.02% |
343,713
+93,100
| +37% | +$3.34M |
|
1114
Hawaiian Electric Industries
HE
$2.28B
| $12.6M | 0.02% |
389,000
+18,700
| +5% | +$622K |
|
1115
Liquidity Services
LQDT
$1.21B
| $12.6M | 0.02% |
1,981,239
+357,240
| +22% | +$2.49M |
|
|
MDSO
1116
DELISTED
Medidata Solutions, Inc.
MDSO
| $12.6M | 0.02% |
160,694
-236,298
| -60% | -$16.5M |
|
|
WGL
1117
DELISTED
Wgl Holdings
WGL
| $12.6M | 0.02% |
+150,600
| New | +$12.5M |
|
1118
Arista Networks
ANET
$215B
| $12.6M | 0.02% |
1,340,800
-1,812,800
| -57% | -$16.4M |
|
1119
Wintrust Financial
WTFC
$10.7B
| $12.5M | 0.02% |
164,000
-23,400
| -12% | -$1.68M |
|
1120
Mesa Laboratories
MLAB
$540M
| $12.5M | 0.02% |
87,271
+7,771
| +10% | +$1.1M |
|
1121
Marriott International
MAR
$101B
| $12.5M | 0.02% |
+124,671
| New | +$12.5M |
|
|
MDCO
1122
DELISTED
Medicines Co
MDCO
| $12.5M | 0.02% |
328,832
+166,500
| +103% | +$7.42M |
|
1123
Hovnanian Enterprises
HOV
$782M
| $12.5M | 0.02% |
178,536
-6,480
| -4% | -$382K |
|
1124
Nelnet
NNI
$4.81B
| $12.5M | 0.02% |
265,200
-60,500
| -19% | -$2.64M |
|
|
DCOM
1125
DELISTED
Dime Community Bancshares
DCOM
| $12.5M | 0.02% |
635,372
-4,700
| -0.7% | -$93.6K |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.